GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » OptimizeRx Corp (NAS:OPRX) » Definitions » Shiller PE Ratio

OptimizeRx (OptimizeRx) Shiller PE Ratio : (As of May. 14, 2024)


View and export this data going back to 2009. Start your Free Trial

What is OptimizeRx Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


OptimizeRx Shiller PE Ratio Historical Data

The historical data trend for OptimizeRx's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptimizeRx Shiller PE Ratio Chart

OptimizeRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OptimizeRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OptimizeRx's Shiller PE Ratio

For the Health Information Services subindustry, OptimizeRx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptimizeRx's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OptimizeRx's Shiller PE Ratio falls into.



OptimizeRx Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

OptimizeRx's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, OptimizeRx's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.24/129.4194*129.4194
=-0.240

Current CPI (Dec. 2023) = 129.4194.

OptimizeRx Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.150 99.695 -0.195
201406 -0.030 100.560 -0.039
201409 -0.030 100.428 -0.039
201412 0.030 99.070 0.039
201503 -0.015 99.621 -0.019
201506 -0.030 100.684 -0.039
201509 0.011 100.392 0.014
201512 -0.043 99.792 -0.056
201603 -0.030 100.470 -0.039
201606 -0.060 101.688 -0.076
201609 -0.030 101.861 -0.038
201612 -0.030 101.863 -0.038
201703 -0.090 102.862 -0.113
201706 -0.040 103.349 -0.050
201709 -0.060 104.136 -0.075
201712 -0.030 104.011 -0.037
201803 -0.020 105.290 -0.025
201806 0.020 106.317 0.024
201809 0.020 106.507 0.024
201812 -0.010 105.998 -0.012
201903 0.000 107.251 0.000
201906 0.030 108.070 0.036
201909 -0.110 108.329 -0.131
201912 -0.140 108.420 -0.167
202003 -0.150 108.902 -0.178
202006 -0.070 108.767 -0.083
202009 -0.020 109.815 -0.024
202012 0.080 109.897 0.094
202103 -0.040 111.754 -0.046
202106 0.020 114.631 0.023
202109 0.002 115.734 0.002
202112 0.030 117.630 0.033
202203 -0.210 121.301 -0.224
202206 -0.210 125.017 -0.217
202209 -0.190 125.227 -0.196
202212 -0.020 125.222 -0.021
202303 -0.370 127.348 -0.376
202306 -0.240 128.729 -0.241
202309 -0.170 129.860 -0.169
202312 -0.240 129.419 -0.240

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OptimizeRx  (NAS:OPRX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


OptimizeRx Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of OptimizeRx's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OptimizeRx (OptimizeRx) Business Description

Traded in Other Exchanges
N/A
Address
400 Water Street, Suite 200, Rochester, MI, USA, 48307
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Executives
Marion Odence-ford officer: General Counsel and CCO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Theresa Greco officer: Chief Commercial Officer 260 CHARLES STREET, SUITE 302, WALTHAM MA 02153
Doug Besch officer: Chief Product Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
William J Febbo officer: Chief Executive Officer 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
James Paul Lang director C/O BIOVIE, 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404
Stephen L Silvestro officer: Chief Commercial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Ellen O'connor Vos director C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Edward Stelmakh officer: COO and CFO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Miriam J Paramore officer: President 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Patrick D Spangler director, officer: SVP of Product & Strategy 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
Douglas P Baker officer: Chief Financial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Todd Inman officer: Chief Technology Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Gregory D Wasson director 200 WILMOT ROAD, DEERFIELD IL 60015
Gus D Halas director 38 PHEASANT RUN PLACE, DANVILLE CA 94506
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022